X
Xeris Biopharma Holdings, Inc. (XERS)
NMS – Real vaqt narxi. Valyuta: USD
8.44
+0.04 (0.54%)
Bozor ochiq: Aug 12, 2026, 11:56 AM EDT
8.27
-0.12 (-1.43%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
8.44
+0.04 (0.54%)
Bozor ochiq: Aug 12, 2026, 11:56 AM EDT
8.27
-0.12 (-1.43%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
This stock has a consensus price target of $9.28 based on the ratings of 9 analysts. The high is $18.00 and the low is $4.50.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 4.5 | $ 9.28 | $ 18 |
| O’zgarish | -45.75% | 11.87% | 117.00% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-02 | 18.55% | HC Wainwright & Co. | $10 → $10 | Reiterates | Buy |
| 2026-01-09 | 18.55% | HC Wainwright & Co. | $10 → $10 | Reiterates | Buy |
| 2025-12-09 | 6.7% | Barclays | $9 | Initiates Coverage On | Overweight |
| 2025-11-07 | 113.4% | Oppenheimer | $18 → $18 | Maintains | Outperform |
| 2025-11-07 | 18.55% | HC Wainwright & Co. | $10 → $10 | Maintains | Buy |